TOP TIERMARKET NEWSWIRE
Movers explained · 2026-11-20

Archived explainer. For the current picture see today's HUM page.

Why Is HUMANA INC (HUM) Stock Up Today?

By the Top Tier Newswire AI Desk · November 20, 2026 at 11:56 AM ET · reviewed against 12 wire stories

HUMANA INC (HUM) is up +5.05% in the latest session. Our newswire has captured 12 stories on HUM across 8 sources in the last 36 hours, with AI sentiment reading mixed (avg 57/100).

Public view, delayed 4h. Every headline, price and sentiment read below — and this write-up itself — reaches Pro subscribers live. Public readers see it once it clears the delay.

Humana (HUM) shares rose 5.05% to $399.19, driven primarily by analyst upgrades from TD Cowen that improved the earnings outlook for the health insurer. The stock had recently faced pressure from regulatory scrutiny and a proposed Medicare for All framework, but the new ratings helped reverse some of the prior decline.

What Happened

TD Cowen upgraded Humana to Buy from Hold, citing an improved earnings outlook and a clearer path to profitability in Medicare Advantage. The firm set a price target of $485 and projected earnings above $40 per share by 2028. This upgrade follows a period of volatility for healthcare insurers, including Humana, UnitedHealth, and CVS Health, which saw shares plunge due to a new Medicare for All proposal and increased regulatory scrutiny of government health programs.

The upgrade comes amid ongoing legal and regulatory concerns. A pending investigation by SueWallSt examines whether Humana adequately disclosed its exposure to proposed Medicare Advantage audits, noting that the program accounts for roughly 80% of premiums. Additionally, a proposed rule allowing Medicare to claw back overbilling going back to 2018 has heightened scrutiny on private insurance plans.

What The Data Shows

The stock opened with a 2.6% gap from the prior close of $380.00, reaching a session high of $401.40 early in the trading day. Volume was 0.5 million shares, which is 0.4x the three-month daily average. Despite the recent gains, the stock remains down 13.3% over the last eight sessions from $438.06. Humana has a market cap of $46.3 billion, a P/E ratio of 37.0, and a net margin of 0.8%. The company’s 52-week range spans from $163.11 to $462.87.

Insider activity shows two sales totaling $2.6 million in the last 90 days, including transactions by Director Frederick Wayne A.I. and General Counsel Ventura Joseph C. Congressional disclosures indicate Donald J. Trump sold between $15,001 and $50,000 in July. Retail chatter on social media has focused on the TD Cowen upgrade and the impact of Medicare Advantage audits, with some users noting the stock’s exposure to regulatory changes.

What To Watch

Investors will monitor the progress of the SueWallSt investigation into Humana’s disclosure practices regarding Medicare Advantage exposure. The scheduled dividend payment of $0.885 per share is set for an effective date of October 30, 2026. Continued coverage of regulatory developments affecting Medicare Advantage profitability remains a key factor for the stock’s trajectory.

AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.

HUM by the numbers

Last: $399.19Session: +5.05%7 sessions: -12.62%Coverage: 12 stories / 8 sourcesAI sentiment: 57/100 (mixed)Mkt cap: $46.3BP/E: 37.052w: $163.11 to $462.87
HUM · Nov 20 session (5-min) · +2.18% vs prior close · updated 3:39 PM ET
$379$391$403prev close $380.00$388.287:00 AM9:08 AM11:17 AM1:26 PM3:35 PM7:00 AM · $389.747:35 AM · $389.007:40 AM · $389.007:55 AM · $388.008:15 AM · $388.008:30 AM · $388.608:35 AM · $388.008:40 AM · $389.448:45 AM · $389.748:50 AM · $389.008:55 AM · $389.749:05 AM · $391.009:10 AM · $391.009:15 AM · $391.809:25 AM · $393.149:30 AM · $396.389:35 AM · $398.989:40 AM · $396.309:45 AM · $393.909:50 AM · $392.129:55 AM · $394.6610:00 AM · $394.8110:05 AM · $398.3810:10 AM · $396.5610:15 AM · $396.2510:20 AM · $395.0110:25 AM · $394.8110:30 AM · $393.2510:35 AM · $395.2110:40 AM · $395.8810:45 AM · $395.0610:50 AM · $395.3910:55 AM · $394.5511:00 AM · $394.2111:05 AM · $394.7311:10 AM · $394.9611:15 AM · $394.0811:20 AM · $394.8811:25 AM · $395.3211:30 AM · $398.1211:35 AM · $397.3711:40 AM · $397.7511:45 AM · $398.3811:50 AM · $399.1611:55 AM · $401.7312:00 PM · $400.3612:05 PM · $400.0712:10 PM · $399.6112:15 PM · $398.9312:20 PM · $397.7612:25 PM · $397.2512:30 PM · $396.6412:35 PM · $395.8912:40 PM · $396.1912:45 PM · $395.8012:50 PM · $395.6112:55 PM · $396.431:00 PM · $395.341:05 PM · $395.381:10 PM · $395.021:15 PM · $397.061:20 PM · $396.271:25 PM · $395.441:30 PM · $394.281:35 PM · $395.731:40 PM · $396.691:45 PM · $397.171:50 PM · $398.451:55 PM · $397.992:00 PM · $397.222:05 PM · $396.632:10 PM · $396.702:15 PM · $395.732:20 PM · $395.062:25 PM · $394.462:30 PM · $393.752:35 PM · $394.042:40 PM · $394.122:45 PM · $392.982:50 PM · $393.482:55 PM · $393.203:00 PM · $392.503:05 PM · $392.183:10 PM · $392.533:15 PM · $392.043:20 PM · $391.213:25 PM · $389.943:30 PM · $388.533:35 PM · $388.28
AI sentiment, last 36h · averaged over 12 stories · 57/100 bullish
AI sentiment 57/100 (bullish)0 · bearish50bullish · 100

The headlines behind the move

Story flow · 8 stories on the wire, last 36h · hover or tap a dot for the headline
36h ago24h ago12h agopublishPR Newswire · sentiment 38 · Humana Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Humana (HUM)PR Newswire · 38Humana Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into H…Seeking Alpha · sentiment 63 · Humana: The Proposed CRUSH Rule Creates A Buying OpportunitySeeking Alpha · 63Humana: The Proposed CRUSH Rule Creates A Buying OpportunityInvesting.com Analyst Ratings · sentiment 64 · TD Cowen upgrades Humana stock rating on earnings outlookInvesting.com Analyst Ratings · 64TD Cowen upgrades Humana stock rating on earnings outlookThe Fly · sentiment 63 · Humana upgraded to Buy from Hold at TD CowenThe Fly · 63Humana upgraded to Buy from Hold at TD CowenThe Fly · sentiment 64 · Cowen Upgrades Unh And Hum Stocks To Buy And Lifts Price Targets After Healthcare Sell Off Heres WhyThe Fly · 64Cowen Upgrades Unh And Hum Stocks To Buy And Lifts Price Targets After Healthcare Sell Of…Seeking Alpha · sentiment 68 · TD Cowen backs UnitedHealth & Humana with buy upgrades, shares riseSeeking Alpha · 68TD Cowen backs UnitedHealth & Humana with buy upgrades, shares riseInvesting.com Markets · sentiment 66 · TD Cowen lifts UnitedHealth, Humana to Buy on improved earnings outlookInvesting.com Markets · 66TD Cowen lifts UnitedHealth, Humana to Buy on improved earnings outlookMarketWatch · sentiment 32 · Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plunging.MarketWatch · 32Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plu…
13h agoMarketWatchBEARISH 32General

Investors fled to healthcare stocks for safety. Now insurance and hospital shares are plunging.

Shares of UnitedHealth, Humana and CVS Health declined this week in light of a new Medicare for All proposal

14h agoInvesting.com MarketsBULLISH 66Analyst

TD Cowen lifts UnitedHealth, Humana to Buy on improved earnings outlook

TD Cowen lifts UnitedHealth, Humana to Buy on improved earnings outlook

16h agoSeeking AlphaBULLISH 68Analyst

TD Cowen backs UnitedHealth & Humana with buy upgrades, shares rise

TD Cowen upgrades UnitedHealth and Humana to Buy, with targets of $455 and $485; it sees Humana above $40 EPS in 2028.

16h agoThe FlyBULLISH 64Analyst

Cowen Upgrades Unh And Hum Stocks To Buy And Lifts Price Targets After Healthcare Sell Off Heres Why

19h agoThe FlyBULLISH 63Analyst

Humana upgraded to Buy from Hold at TD Cowen

23h agoInvesting.com Analyst RatingsBULLISH 64Analyst

TD Cowen upgrades Humana stock rating on earnings outlook

TD Cowen upgrades Humana stock rating on earnings outlook

1d agoSeeking AlphaBULLISH 63Analyst

Humana: The Proposed CRUSH Rule Creates A Buying Opportunity

Humana is especially exposed to proposed Medicare Advantage audits, with the program accounting for roughly 80% of premiums. I rate HUM stock as Buy.

1d agoPR NewswireBEARISH 38General

Humana Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Humana (HUM)

Selling your HUM shares after the November 18 Medicare Advantage selloff does not necessarily end your rights. SueWallSt notifies investors of a pending investigation into whether Humana adequately disclosed its exposure to Medicare Advantage audit and repayment risk. NEW YORK, Nov. 19,...

Want the next move before the crowd? The live terminal streams every headline in real time with watchlist alerts, AI sentiment, and the full data stack behind this page.Get Pro Access →

More on HUM: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.

Earlier HUM move explainers: 2026-11-20 · 2026-11-19 · 2026-11-18 · 2026-11-17 · 2026-10-12 · 2026-10-09 · 2026-09-25